David Vocadlo, PhD
Professor and Canada Research Chair in Chemical Biology at Simon Fraser University
Location: British Columbia, Canada
Dr. David Vocadlo obtained his PhD from the University of British Columbia in 2002 and completed a post-doctoral fellowship at the University of California at Berkeley in the Departments of Chemistry and Molecular and Cell Biology (2002-2003). In 2004, he moved to Simon Fraser University where he is currently a professor in the Departments of Chemistry and Molecular Biology & Biochemistry and a Tier I Canada Research Chair in chemical biology. Dr. Vocadlo's research focuses on developing chemical biology tools to advance our understanding of the mechanisms of glycoconjugates (carbohydrates linked to other substances) in disease. Dr. Vocadlo pioneered the development and pre-clinical validation of O-GlcNAcase (type of enzyme) inhibitors for neurodegenerative diseases, a strategy that has advanced into clinical testing. His research has been recognized with various awards, including the E.W.R. Steacie Memorial Fellowship, the Horace Isbell Award from the American Chemical Society and appointment as an inaugural member of the Royal Society of Canada, College of New Scholars.